Management of dyslipidemia in children
- PMID: 19995441
- PMCID: PMC2794840
- DOI: 10.1186/1758-5996-1-26
Management of dyslipidemia in children
Abstract
Dyslipidemia is an important etiologic factor in the development of cardiovascular disease (CVD), which is a leading cause of death worldwide. As CVD begins in childhood, and as dyslipidemia is an important risk factor for CVD, screening and treatment of dyslipidemia in adolescents and children becomes an important health matter. This review deals with issues related to screening, diagnosis and treatment of dyslipidemia in children and adolescents.
Similar articles
-
The current state of dyslipidemia in Korean children and adolescents and its management in clinical practice.Ann Pediatr Endocrinol Metab. 2013 Mar;18(1):1-8. doi: 10.6065/apem.2013.18.1.1. Epub 2013 Mar 31. Ann Pediatr Endocrinol Metab. 2013. PMID: 24904843 Free PMC article. Review.
-
Recognition and management of dyslipidemia in children and adolescents.J Clin Endocrinol Metab. 2008 Nov;93(11):4200-9. doi: 10.1210/jc.2008-1270. Epub 2008 Aug 12. J Clin Endocrinol Metab. 2008. PMID: 18697860 Review.
-
Dyslipidemia and cardiovascular disease risk factors in patients with type 1 diabetes: A single-center experience.World J Diabetes. 2021 Jan 15;12(1):56-68. doi: 10.4239/wjd.v12.i1.56. World J Diabetes. 2021. PMID: 33520108 Free PMC article.
-
Genetic polymorphisms as a risk factor for dyslipidemia in children.J Pediatr Genet. 2013 Jun;2(2):69-75. doi: 10.3233/PGE-13050. J Pediatr Genet. 2013. PMID: 27625842 Free PMC article. Review.
-
Lipoprotein (a): Examination of Cardiovascular Risk in a Pediatric Referral Population.Pediatr Cardiol. 2018 Dec;39(8):1540-1546. doi: 10.1007/s00246-018-1927-3. Epub 2018 Jun 13. Pediatr Cardiol. 2018. PMID: 29948030
Cited by
-
Insulin-resistance in paediatric age: Its magnitude and implications.World J Diabetes. 2022 Apr 15;13(4):282-307. doi: 10.4239/wjd.v13.i4.282. World J Diabetes. 2022. PMID: 35582667 Free PMC article. Review.
-
Adiponectin is associated with cardio-metabolic traits in Mexican children.Sci Rep. 2019 Feb 28;9(1):3084. doi: 10.1038/s41598-019-39801-2. Sci Rep. 2019. PMID: 30816311 Free PMC article.
-
Pediatric hyperlipidemia.Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S104-S107. doi: 10.1016/j.ihj.2023.11.269. Epub 2024 Apr 8. Indian Heart J. 2024. PMID: 38599724 Free PMC article. Review.
-
Genetic markers of inflammation may not contribute to metabolic traits in Mexican children.PeerJ. 2016 Jun 23;4:e2090. doi: 10.7717/peerj.2090. eCollection 2016. PeerJ. 2016. PMID: 27366637 Free PMC article.
-
Serum YKL-40 Levels Are Associated with the Atherogenic Index of Plasma in Children.Mediators Inflamm. 2020 Sep 26;2020:8713908. doi: 10.1155/2020/8713908. eCollection 2020. Mediators Inflamm. 2020. PMID: 33061832 Free PMC article.
References
-
- Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T. For the Writing Group and Members of the Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2006 update: A report from the American Heart Association Statistic Committee and Stroke Statistic Subcommittee. Circulation. 2006;113:e85–e151. doi: 10.1161/CIRCULATIONAHA.105.171600. - DOI - PubMed
-
- McGill HC Jr, Mcmahan CA, Zieske AW, Malcom GT, Tracy RE, Strong JP. for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation. 2001;103:1546–1550. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials